Overactive Bladder

Overactive bladder (OAB) is a prevalent condition, particularly among women, and is associated with substantial economic and quality-of-life burdens. Although stress urinary incontinence during and after pregnancy is well documented, the association between childbirth and OAB symptoms remains unclear.

Overactive bladder (OAB) is defined as 'urinary urgency with or without urinary urgency incontinence (UUI), usually associated with urinary frequency and/or nocturia, in the absence of urinary tract infection'.

To quantitatively determine whether the clinical benefit of mirabegron plus solifenacin for overactive bladder (OAB) reflects pharmacological synergy or independent drug action.

We conducted a post hoc quantitative reanalysis of the SYNERGY study comparing solifenacin monotherapy, mirabegron monotherapy, and their combinations (S5+M25, S5+M50).

We examined whether accelerometer-derived rest-activity rhythms (RAR) and multidimensional sleep metrics are associated with overactive bladder (OAB) and whether depression may partially account for this relationship.

Overactive bladder (OAB) is highly prevalent among women. Energy-based treatments, such as radiofrequency (RF), have shown promising results in urinary incontinence, but evidence for OAB remains limited.

Sacral neuromodulation (SNM) is a therapeutic option offered to patients with idiopathic overactive bladder (OAB) or non-obstructive urinary retention, as an alternative treatment for refractory medical management.

Overactive bladder (OAB) is prevalent among older adults and may substantially affect health-related quality of life (HRQoL). This study aimed to describe HRQoL status among community-dwelling older adults with OAB and examine the relationship between OAB symptom severity and HRQoL.

Ioannis Loufopoulos and colleagues conducted a thorough review of 30 selected studies, from an initial pool of 1,224, to address whether persistent overactive bladder/storage symptoms can be predicted after deobstruction surgery for benign prostatic hyperplasia (BPH). In all, 8,043 patients were included.

Overactive bladder (OAB) is a prevalent condition associated with impaired quality of life, yet many patients do not pursue treatment or minimally invasive therapies (MIT). Physician-patient concordance has been proposed as a factor influencing trust, although its role in OAB care is not well defined.

Benign prostatic hyperplasia (BPH) and overactive bladder (OAB) both cause lower urinary tract symptoms (LUTS) in men. Ongoing urgency, frequency, and nocturia despite effective BPH management may indicate coexistence of primary OAB in many individuals.